DFTX
Definium Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$35.28
+7.00%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.56
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$1.44
- EPS estimate
- -$0.54
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -73.0%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $74
- PT range
- $55 – $90
- Analysts
- 11
11 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.54 | -$1.44 | Miss -166.16% | — |
| May 7, 2026 | -$0.49 | -$0.71 | Miss -44.27% | — |
| Nov 6, 2025 | -$0.52 | -$0.78 | Miss -50.00% | — |
| Jul 31, 2025 | -$0.38 | -$0.50 | Miss -31.58% | — |
| May 8, 2025 | -$0.36 | -$0.35 | Beat 2.78% | — |
| Mar 6, 2025 | -$0.33 | -$0.41 | Miss -24.24% | — |
| Nov 7, 2024 | -$0.29 | -$0.27 | Beat 6.90% | — |
| Feb 28, 2024 | -$0.48 | -$0.59 | Miss -22.92% | $4.8M |
| Nov 2, 2023 | -$0.65 | -$0.53 | Beat 18.46% | — |
| Aug 3, 2023 | -$0.54 | -$0.72 | Miss -33.33% | — |
| May 4, 2023 | -$0.41 | -$0.51 | Miss -24.39% | — |
| Mar 9, 2023 | -$0.49 | -$0.27 | Beat 44.90% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026